Kay Savage worked at Leica Biosystems Newcastle as a Principal Scientist in the Antibody Development group. Her main responsibilities were as a subject matter expert in immunohistochemistry, responsible for the development and characterization of antibody products, and the generation of product claims. Dr. Savage previously worked for over ten years in the Histopathology department at the Royal Free Hospital in London, where she worked on her PhD in pathology on the pathology of Hepatitis C virus, as well as other immunohistochemistry-based research projects on melanomas, colon, and gastric cancer. Her previous role was five years as senior scientist then laboratory manager at the pathology core facility for Breakthrough Breast Cancer at the Institute of Cancer Research in London, where her main responsibilities were optimization of novel antibodies for use on FFPE tissues, production of tissue microarrays for use in breast cancer research, and providing a histological service to the research institute.
